Drug Shortage Report for TERAZOSIN
Report ID | 135430 |
Drug Identification Number | 02350483 |
Brand name | TERAZOSIN |
Common or Proper name | TERAZOSIN |
Company Name | SANIS HEALTH INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TERAZOSIN |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-03-10 |
Estimated end date | Unknown |
Actual end date | 2024-03-01 |
Shortage status | Resolved |
Updated date | 2024-03-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-03-02 | English | Compare |
v5 | 2024-03-01 | French | Compare |
v4 | 2024-03-01 | English | Compare |
v3 | 2021-03-11 | English | Compare |
v2 | 2021-03-10 | French | Compare |
v1 | 2021-03-10 | English | Compare |
Showing 1 to 6 of 6